Pérez-Torres E

Language: Spanish
References: 15
Page: 287-290
PDF size: 54.42 Kb.

ABSTRACT

Objective: We undertook this study to determine the morbimortality in surgery for gastric carcinoma.
Methods: We carried out a retrospective, observational study performed at the Gastroenterology Service of the General Hospital of Mexico City between January 2004 and October 2005. Variables included sex, age, diagnosis, surgery performed and trans- and postoperative complications.
Results: Clinical files of 2208 patients were reviewed: 36 (1.63%) cases with gastric carcinoma were found. Twenty patients fulfilled inclusion criteria; there were nine (45%) females and 11 (55%) males with a median age of 60.3 years. Radiological studies performed were upper gastrointestinal series, esophagogastroduodenoscopy, chest x-ray, and computed tomography (CT). Localization of the tumors was as follows: 15 in the antrum, three in the fundus and body and two in the body portion of the stomach. Clinical staging was T3 N0 M0. Surgical procedures were as follows: 11 subtotal gastrectomies and 4 gastrojejunostomies. In three cases, total gastrectomy was done and in two cases lymphatic biopsy was done. No mortality was reported. Morbidity was reported in one case (5%) with enterocutaneous fistula.
Conclusions: Surgery is the treatment for gastric carcinoma. Preoperative staging is done with CT and laparoscopy. There was no mortality in our study. Morbidity is similar to that reported by other hospitals.

REFERENCES

1. Oñate FL, Mondragón SR, Ruiz JM, Ochoa CF, Aiello CV. Cáncer gástrico. Rev Gastroenerol Mex 1997;62:160-166.

2. Pérez TE. Cáncer gástrico. En: Murguía DD, ed. Gastroenterología y Hepatología Práctica. México: Intersistemas;1999. pp. 63-71.

3. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer 2002;5:1-5.

4. Ho S. Tumores de estómago e intestino delgado. En: Friedman JC, ed. Diagnóstico y Tratamiento en Gastroenterología. 2ª ed. México: El Manual Moderno;2003. pp. 417-430.

5. Etchegaray DA. Cáncer gástrico. México: Asociación Mexicana de Cirugía General, Consejo Mexicano de Cirugía General, El Manual Moderno;2003. pp. 673-682.

6. Wang JY, Hsieh JS, Huang CJ, Huang YS, Huang TJ. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients. J Surg Oncol 1996;63:36-40.

7. Dicken JB, Bigam D, Mackey J, Joy A, Hamilton SM. Gastric adenocarcinoma. Review and considerations for future directions. Ann Surg 2005;24:27-39.

8. Bozzetti F, Marubin E, Bonfanti G. Subtotal versus total gastrectomy for gastric cancer: five year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170-178.

9. Trill DS, Danjuanbenito D, Fernández BL, Luisa N. Gastric adenocarcinoma. Our experience with radical lymphadenectomy. Rev Oncol 2003;5:286-290.

10. Kodera Y, Schawarz RE, Nakao A. Extendend lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials? J Am Coll Surg 2002;195:855-864.

11. Maruyama K, Gunven P, Olcabayashi K. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 1989;210:596-602.

12. Shchepotin BI, Chorny AV, Nauta JR, Shabahang M. Extended surgical resection in T4 gastric cancer. Am J Surg 1998;175:123-126.

13. McDonald JS, Smalley SR, Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-730.

14. Yao CJ, Mansfield FD, Pisters WP, Feig WB, Janjan AN. Combined modality therapy for gastric cancer. Sem Surg Oncol 2003;21:223-227.

15. Anzures LM. Manejo quirúrgico del cáncer gástrico. En: Clínicas del Hospital General de México. Gastroenterología Quirúrgica. México: Siembra; 2005(9). pp. 41-50.